Give us a call 215-275-1556

Whitelaw Compliance Group

helping companies grow sustainable integrity™
Get Started Today

Every acorn on the ground is just as alive as the three-hundred-year-old oak tree that towers over it.

– Hope Jahren

Providing Practical Compliance From Deeply Rooted Expertise and Experience To Make A Difference for Our Clients

Our Focus

Whitelaw Compliance Group focuses on emerging health care companies and organizations.  We believe that from humble acorns mighty oaks will grow.  We also know that every client deserves high-quality, practical compliance that fits the organization’s needs and grows as the company grows.  We do this by listening and focusing on one client at a time. 

Our Expertise and Experience

With almost 30 years working in and with healthcare companies, and having designed, built and run 4 different compliance programs, we know from experience what works.  We also know how to fit the pieces together to get things done as quickly and efficiently giving us the ability to create innovative, effective compliance, because “out-of-the box” compliance solutions simply won’t do.

Compliance Blog

We Offer a Wide Range of Services

With our flexible, efficient, and experienced approach,  Whitelaw Compliance Group  can provide a wide range of solutions, custom-tailored to meet each individual client’s needs and budget. Our services include:

  • Compliance vision and risk strategy for the present and future
  • Program health-checks and CIA readiness assessments
  • Board of Director expert services, training, and support
  • Interim department staffing
  • Policy and SOP development
  • Process development and execution
  • Helpline creation and management
  • Investigation process development and execution
  • Staff training and knowledge enhancement
  • Regulatory response and remediation
  • Serving as an Expert Witness

Company News & Recent Articles

News

MITCHELL HAMLINE SCHOOL OF LAW

 This summer Dr. Whitelaw will be teaching a new course entitled: 

 Health Care Law & Opioids: How the “Man-Made Plague” Is Transforming the Pharmaceutical Industry

 The current opioid crisis also has generated an enormous amount of federal, state, and local litigation, much of which is ongoing. However, it is clear, even though the litigation is far from over, that the aftermath of the opioid cases will transform the pharmaceutical industry in much the same way that the big tobacco cases did.

 With the amount of information that is publicly available (e.g., media coverage, case evidence, pleadings, settlements and verdicts), the opioid crisis and its attendant litigation present students with a unique opportunity to explore the intersection between public health, regulations, compliance, and the law.  

 

 

 

Articles

Opioid Crisis:  Whitelaw, S., When Money and Doritos Don’t Suffice – The Crucial Imperative for Integrating Effective Compliance Controls In The Ongoing Opioid Settlements, 5.10 Policy & Medicine Compliance Update, 1 (2019).

Drug Pricing:  Whitelaw, Seth; Fiorentino, Nicodemo; and O’Leary, Jennifer (2018) “Drug Pricing—The Next Compliance Waterloo,” Mitchell Hamline Law Review: Vol. 44 : Iss. 4 , Article 2.

Policy & Medicine Articles

Opioid Crisis:  Burning Down the House – Lessons from the Insys Therapeutics Saga, vol. 6, issue 6 (co-authored with Robert N. Wilkey, Esq.)

Governance & Operations:  Redressing Corporate Misdeeds — Is Holding Individuals Accountable the Answer? vol. 6, issue 1, 14 (co-authored with Nicodemo Fiorentino, Esq.)

Opioid Crisis: Spreading the Blame – DEA Criticized for Its Role in the Opioid Crisis, vol. 5, issue 11, 23.

 Real World Evidence: Data in the “Real World” – The Future?, vol. 5, issue 8, 10 (co-authored with David Vulcano, LSCW, MBA, CIP, RAC).

 Transparency: Another Twist on Transparency – Transparency in Litigation, vol. 5, issue 6, 13.